ONCOLYTICS BIOTECH INC. Deductible Temporary Differences For Which No Deferred Tax Asset Is Recognised
ONCOLYTICS BIOTECH INC. (ONCY) had Deductible Temporary Differences For Which No Deferred Tax Asset Is Recognised of CAD 52.02 million as of 2024-12-31, per its 20-F filed 2025-03-07.
Financial Statements › Notes › Income Taxes
ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised · last filed 2025-03-07
- 2024-12-31: Deductible Temporary Differences For Which No Deferred Tax Asset Is Recognised 52.02M CAD.
- 2023-12-31: Deductible Temporary Differences For Which No Deferred Tax Asset Is Recognised 49.26M CAD.
- 2022-12-31: Deductible Temporary Differences For Which No Deferred Tax Asset Is Recognised 38.63M CAD.
- 2021-12-31: Deductible Temporary Differences For Which No Deferred Tax Asset Is Recognised 37.58M CAD; Deductible Temporary Differences For Which No Deferred Tax Asset Is Recognised as first filed 37.58M CAD.
| Period end | Deductible Temporary Differences For Which No Deferred Tax Asset Is Recognised | Deductible Temporary Differences For Which No Deferred Tax Asset Is Recognised as first filed |
|---|---|---|
| 2024-12-31 | 52.02M CAD 20-F · filed 2025-03-07 | |
| 2023-12-31 | 49.26M CAD 20-F · filed 2025-03-07 | |
| 2022-12-31 | 38.63M CAD 20-F · filed 2025-03-07 | |
| 2021-12-31 | 37.58M CAD 20-F · filed 2024-03-12 | 37.58M CAD 20-F · filed 2022-03-03 |
| 2020-12-31 | 34.54M CAD 20-F · filed 2023-03-03 | 34.54M CAD 20-F · filed 2021-03-05 |
| 2019-12-31 | 32.71M CAD 20-F · filed 2022-03-03 | |
| 2018-12-31 | 34.71M CAD 20-F · filed 2021-03-05 | |
| 2017-12-31 | 32.98M CAD 20-F · filed 2020-03-06 | |
| 2016-12-31 | 31.56M CAD 20-F · filed 2019-03-15 | |
| 2015-12-31 | 29.68M CAD 20-F · filed 2018-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |